Calculate the infusion time for an IV of 1,500 mL running at 25 gtt/min. if the drop factor is 15 gtt/mL.
The Correct Answer is ["36"]
To calculate the infusion time for an IV of 1,500 mL running at 25 gtt/min. if the drop factor is 15 gtt/mL, we need to use the following formula:
Infusion time (in minutes) = Volume (in mL) x Drop factor (in gtt/mL) / Flow rate (in gtt/min)
Plugging in the given values, we get:
Infusion time = 1,500 x 15 / 25
Infusion time = 900 / 25
Infusion time = 36
Therefore, the infusion time for this IV is 36 minutes.
Nursing Test Bank
Naxlex Comprehensive Predictor Exams
Related Questions
Correct Answer is D
Explanation
A. Calm the patient to reduce acid production.
This description is not accurate for sucralfate. Calming the patient to reduce acid production is typically associated with medications like proton pump inhibitors (PPIs) or H2 receptor blockers.
B. Block the H2 receptors.
Blocking H2 receptors is the mechanism of action for H2 receptor blockers, such as ranitidine. It is not the mechanism of action for sucralfate.
C. Neutralize the gastric acids.
Neutralizing gastric acids is the mechanism of action for antacids, such as aluminum hydroxide or calcium carbonate. Sucralfate works differently; it forms a protective coating on the gastric lining rather than directly neutralizing acids.
D. Coat the gastric lining.
This is the correct mechanism of action for sucralfate. It forms a protective coating on the gastric lining, adhering to the ulcer site and providing a barrier against gastric acid.
Correct Answer is A
Explanation
A. Carbidopa-levodopa
The symptoms described, including a shuffling gait, lack of facial expression, and tremors at rest, are characteristic of Parkinson's disease. Carbidopa-levodopa is a common medication used in the management of Parkinson's disease.
B. Donepezil
Donepezil is used in the treatment of Alzheimer's disease, a condition characterized by cognitive decline and memory impairment. It is not indicated for Parkinson's disease.
C. Rivastigmine
Rivastigmine is another medication used in the treatment of Alzheimer's disease, and it is also used in Parkinson's disease dementia. However, it is not the primary medication for the motor symptoms of Parkinson's disease.
D. Tacrine
Tacrine was once used in the treatment of Alzheimer's disease, but it is no longer commonly prescribed due to safety concerns and the availability of newer, safer medications. It is not indicated for Parkinson's disease.
Whether you are a student looking to ace your exams or a practicing nurse seeking to enhance your expertise , our nursing education contents will empower you with the confidence and competence to make a difference in the lives of patients and become a respected leader in the healthcare field.
Visit Naxlex, invest in your future and unlock endless possibilities with our unparalleled nursing education contents today